These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5361571)

  • 1. Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions.
    Lopez M; Bloch KJ
    J Immunol; 1969 Dec; 103(6):1428-30. PubMed ID: 5361571
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive cutaneous anaphylaxis in the rat, induced with two homologous reagin-like antibodies and its specific inhibition with disodium cromoglycate.
    Goose J; Blair AM
    Immunology; 1969 Jun; 16(6):749-60. PubMed ID: 4306785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of disodium cromoglycate on the anaphylactic mediator release].
    Koda A; Nagai H; Hiramatsu M; Katsuta E
    Arerugi; 1970 Aug; 19(8):597-604. PubMed ID: 4989823
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.
    Orr TS; Gwilliam J; Cox JS
    Immunology; 1970 Sep; 19(3):469-79. PubMed ID: 5471831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of carbamylation, amidination and benzylation on the ability of rabbit gamma-G antibody to produce passive cutaneous anaphylaxis in guinea pig and rabbit skin.
    Cohen S; Feinman L; Becker EL
    J Immunol; 1969 Sep; 103(3):387-94. PubMed ID: 4979774
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibiting effect of disodium chromoglycate (Intal) on passive cutaneous anaphylaxis in rats].
    Sudo M; Yoshida T
    Arerugi; 1970 Apr; 19(4):250-9. PubMed ID: 5448916
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression by antihistamine of passive cutaneous anaphylaxis produced with anaphylactic antibody in the guinea pig.
    Movat HZ; Di Lorenzo NL; Taichman NS; Berger S; Stein H
    J Immunol; 1967 Feb; 98(2):230-5. PubMed ID: 4381269
    [No Abstract]   [Full Text] [Related]  

  • 8. The latency requirements and rate of evolution of passive cutaneous anaphylactic reactions produced by untreated and carbamylated rabbit gamma-G antibody.
    Feinman L; Cohen S; Becker EL
    J Immunol; 1969 Sep; 103(3):395-402. PubMed ID: 5805426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Decomplementization by a factor extracted from cobra venom. Effect on several immune reactions of the guinea pig and rat].
    Maillard JL; Zarco RM
    Ann Inst Pasteur (Paris); 1968 Jun; 114(6):756-74. PubMed ID: 4255485
    [No Abstract]   [Full Text] [Related]  

  • 10. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.
    Cox JS
    Nature; 1967 Dec; 216(5122):1328-9. PubMed ID: 6080064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of predosing with Y-12,141 on its antiallergic activity. --Studies on anti-allergic agents(IV)-- (author's transl)].
    Goto K; Terasawa M; Komori A; Maruyama Y
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):123-9. PubMed ID: 6786963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oxyphenbutazone on immunologic reactions. 2. Passive cutaneous anaphylaxis (PCA) treated with oxyphenbutazone, cortisone and cyclophosphamide].
    Horsch A; Rapp W
    Arzneimittelforschung; 1971 Jun; 21(6):769-72. PubMed ID: 5109255
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of cellular anaphylaxis by beta-stimulants.
    Martin LE
    Postgrad Med J; 1971 Mar; 47():Suppl:26-30. PubMed ID: 4102079
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.
    Assem ES; Richter AW
    Immunology; 1971 Nov; 21(5):729-39. PubMed ID: 4107218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical mechanisms of immediate-type hypersensitivity reactions.
    Stanworth DR
    Clin Exp Immunol; 1970 Jan; 6(1):1-12. PubMed ID: 4190339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of passive cutaneous anaphylaxis by dipeptides].
    Ado AD; Alekseeva TA; Lukmanova FF
    Biull Eksp Biol Med; 1977 Oct; 84(10):460-2. PubMed ID: 912059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaphylactic antibodies].
    Pardoe GI; Uhlenbruck G
    Dtsch Med Wochenschr; 1969 Jun; 94(23):1248-53. PubMed ID: 4181314
    [No Abstract]   [Full Text] [Related]  

  • 18. BRL 22321. A compound with similarities to both disodium cromoglycate and theophylline.
    Smith H; Ross JW; Spicer BA; Clarke GD; Harling EJ; Hassall PA; Taylor JF
    Monogr Allergy; 1983; 18():223-5. PubMed ID: 6196629
    [No Abstract]   [Full Text] [Related]  

  • 19. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments concerned with the mode of action of disodium cromoglycate (Intal).
    Cox JS
    Arerugi; 1970 Nov; 19(11):832-5. PubMed ID: 4922991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.